These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17579511)

  • 61. Pandemic vaccines: promises and pitfalls.
    Booy R; Brown LE; Grohmann GS; Macintyre CR
    Med J Aust; 2006 Nov; 185(S10):S62-5. PubMed ID: 17115955
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Control measures in an influenza pandemic in Switzerland].
    Bernasconi D; Steffen R
    Soz Praventivmed; 1997; 42 Suppl 2():S92-9. PubMed ID: 9454476
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Australian response: pandemic influenza preparedness.
    Horvath JS; McKinnon M; Roberts L
    Med J Aust; 2006 Nov; 185(s10):S35-8. PubMed ID: 17115949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada.
    Champredon D; Laskowski M; Charland N; Moghadas SM
    Sci Rep; 2018 Apr; 8(1):6492. PubMed ID: 29691450
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context.
    Grieco L; Panovska-Griffiths J; van Leeuwen E; Grove P; Utley M
    Vaccine; 2020 Jul; 38(33):5163-5170. PubMed ID: 32576461
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of vaccination and population structure on influenza epidemic spread in the presence of two circulating strains.
    Alexander ME; Kobes R
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S8. PubMed ID: 21356137
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The development of global vaccine stockpiles.
    Yen C; Hyde TB; Costa AJ; Fernandez K; Tam JS; Hugonnet S; Huvos AM; Duclos P; Dietz VJ; Burkholder BT
    Lancet Infect Dis; 2015 Mar; 15(3):340-7. PubMed ID: 25661473
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Community interventions and the epidemic prevention potential.
    Halloran ME; Longini IM; Cowart DM; Nizam A
    Vaccine; 2002 Sep; 20(27-28):3254-62. PubMed ID: 12213394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Measures of the effects of vaccination in a randomly mixing population.
    Haber M; Longini IM; Halloran ME
    Int J Epidemiol; 1991 Mar; 20(1):300-10. PubMed ID: 2066239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinguishing vaccine efficacy and effectiveness.
    Shim E; Galvani AP
    Vaccine; 2012 Oct; 30(47):6700-5. PubMed ID: 22944629
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great Britain.
    Keeling MJ; White PJ
    J R Soc Interface; 2011 May; 8(58):661-70. PubMed ID: 20943682
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Infection control and pandemic influenza.
    Collignon PJ; Carnie JA
    Med J Aust; 2006 Nov; 185(S10):S54-7. PubMed ID: 17115953
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pandemic influenza preparedness: the critical role of the syringe.
    Strauss K; van Zundert A; Frid A; Costigliola V
    Vaccine; 2006 May; 24(22):4874-82. PubMed ID: 16647790
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparedness for pandemics: does variation among states affect the nation as a whole?
    Potter MA; Brown ST; Lee BY; Grefenstette J; Keane CR; Lin CJ; Quinn SC; Stebbins S; Sweeney PM; Burke DS
    J Public Health Manag Pract; 2012; 18(3):233-40. PubMed ID: 22473116
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model.
    Nizolenko LP; Bachinsky AG; Bazhan SI
    Biomed Res Int; 2016; 2016():5952890. PubMed ID: 27668256
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimizing influenza vaccine policies for controlling 2009-like pandemics and regular outbreaks.
    Chen SI; Wu CY; Wu YH; Hsieh MW
    PeerJ; 2019; 7():e6340. PubMed ID: 30713821
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influenza vaccination in 22 developed countries: an update to 1995.
    Fedson DS; Hirota Y; Shin HK; Cambillard PE; Kiely J; Ambrosch F; Hannoun C; Leese J; Sprenger MJ; Hampson AW; Bro-Jørgensen K; Ahlbom AM; Nøkleby H; Valle M; Olafsson O; Salmerón F; Cloetta J; Rebelo de Andrade H; Snacken R; Donatelli I; Jennings LC; Strikas RA
    Vaccine; 1997 Oct; 15(14):1506-11. PubMed ID: 9330460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mathematical assessment of Canada's pandemic influenza preparedness plan.
    Gumel AB; Nuño M; Chowell G
    Can J Infect Dis Med Microbiol; 2008 Mar; 19(2):185-92. PubMed ID: 19352450
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influenza vaccination in 18 developed countries, 1980-1992.
    Fedson DS; Hannoun C; Leese J; Sprenger MJ; Hampson AW; Bro-Jørgensen K; Ahlbom AM; Nøkelby H; Valle M; Olafsson O
    Vaccine; 1995 May; 13(7):623-7. PubMed ID: 7668032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.